US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist
  • 0.1300
  • +0.0064+5.18%
Close Nov 21 16:00 ET
  • 0.1276
  • -0.0024-1.85%
Post 19:59 ET
7.47MMarket Cap-2P/E (TTM)

CNS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
666.66%6.97M
-65.14%1.49M
-84.05%815.23K
-94.54%548.72K
-94.54%548.72K
-87.06%909.55K
-52.23%4.28M
-58.92%5.11M
100.93%10.06M
100.93%10.06M
-Cash and cash equivalents
666.66%6.97M
-65.14%1.49M
-84.05%815.23K
-94.54%548.72K
-94.54%548.72K
-87.06%909.55K
-52.23%4.28M
-58.92%5.11M
100.93%10.06M
100.93%10.06M
Current deferred assets
--26.93K
--16.75K
--0
--202.86K
--202.86K
----
----
----
--0
--0
Other current assets
-66.32%388.04K
-64.44%637.09K
-57.78%786.05K
-66.54%839.59K
-66.54%839.59K
-31.12%1.15M
-26.52%1.79M
-18.80%1.86M
1.47%2.51M
1.47%2.51M
Total current assets
258.32%7.39M
-64.66%2.15M
-77.03%1.6M
-87.34%1.59M
-87.34%1.59M
-76.30%2.06M
-46.73%6.07M
-52.68%6.97M
68.03%12.56M
68.03%12.56M
Non current assets
Net PPE
-19.25%2.8K
5.06%3.55K
-1.82%4.31K
-12.91%4.93K
-12.91%4.93K
-59.28%3.47K
-69.17%3.38K
-65.56%4.39K
-64.84%5.66K
-64.84%5.66K
Non current prepaid assets
-93.01%18.37K
-15.08%320.32K
-87.38%55.3K
-78.30%104.75K
-78.30%104.75K
-55.84%262.73K
-46.48%377.2K
-44.67%438.13K
-48.07%482.81K
-48.07%482.81K
Total non current assets
-92.05%21.18K
-14.90%323.87K
-86.53%59.6K
-77.55%109.68K
-77.55%109.68K
-71.61%266.2K
-63.75%380.58K
-61.14%442.52K
-61.84%488.47K
-61.84%488.47K
Total assets
218.26%7.41M
-61.73%2.47M
-77.60%1.66M
-86.97%1.7M
-86.97%1.7M
-75.84%2.33M
-48.17%6.45M
-53.28%7.41M
49.05%13.05M
49.05%13.05M
Liabilities
Current liabilities
Payables
----
----
----
----
----
300.67%4.03M
627.39%3.57M
467.80%2.78M
----
----
-accounts payable
----
----
----
----
----
300.67%4.03M
627.39%3.57M
467.80%2.78M
----
----
Current accrued expenses
----
----
----
----
----
----
-5.94%260.14K
177.91%853.23K
----
----
Current debt and capital lease obligation
-25.58%31.19K
-25.93%123.25K
-26.28%213.1K
-26.63%300.81K
-26.63%300.81K
6.73%41.9K
6.39%166.4K
6.05%289.08K
5.72%409.97K
5.72%409.97K
-Current debt
-25.58%31.19K
-25.93%123.25K
-26.28%213.1K
-26.63%300.81K
-26.63%300.81K
6.73%41.9K
6.39%166.4K
6.05%289.08K
5.72%409.97K
5.72%409.97K
Current liabilities
-0.29%4.06M
69.19%6.76M
55.28%6.09M
24.65%6.13M
24.65%6.13M
226.99%4.07M
332.66%4M
266.87%3.92M
89.66%4.92M
89.66%4.92M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-0.29%4.06M
69.19%6.76M
55.28%6.09M
24.65%6.13M
24.65%6.13M
226.99%4.07M
332.66%4M
266.87%3.92M
89.66%4.92M
89.66%4.92M
Shareholders'equity
Share capital
695.01%33.45K
-65.15%1.44K
379.29%10.67K
284.29%6.21K
284.29%6.21K
-89.49%4.21K
-89.66%4.14K
-94.44%2.23K
70.39%1.62K
70.39%1.62K
-common stock
695.01%33.45K
-65.15%1.44K
379.29%10.67K
284.29%6.21K
284.29%6.21K
-89.49%4.21K
-89.66%4.14K
-94.44%2.23K
70.39%1.62K
70.39%1.62K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-26.57%-81.25M
-26.77%-75.64M
-31.38%-73.11M
-37.17%-69.57M
-37.17%-69.57M
-43.44%-64.19M
-44.36%-59.67M
-47.34%-55.65M
-43.10%-50.72M
-43.10%-50.72M
Paid-in capital
35.42%84.57M
14.86%71.35M
16.12%68.67M
10.67%65.13M
10.67%65.13M
17.59%62.45M
17.61%62.12M
12.58%59.14M
41.45%58.85M
41.45%58.85M
Total stockholders'equity
292.58%3.35M
-274.93%-4.29M
-226.88%-4.43M
-154.50%-4.43M
-154.50%-4.43M
-120.74%-1.74M
-78.70%2.45M
-76.41%3.49M
31.96%8.13M
31.96%8.13M
Total equity
292.58%3.35M
-274.93%-4.29M
-226.88%-4.43M
-154.50%-4.43M
-154.50%-4.43M
-120.74%-1.74M
-78.70%2.45M
-76.41%3.49M
31.96%8.13M
31.96%8.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 666.66%6.97M-65.14%1.49M-84.05%815.23K-94.54%548.72K-94.54%548.72K-87.06%909.55K-52.23%4.28M-58.92%5.11M100.93%10.06M100.93%10.06M
-Cash and cash equivalents 666.66%6.97M-65.14%1.49M-84.05%815.23K-94.54%548.72K-94.54%548.72K-87.06%909.55K-52.23%4.28M-58.92%5.11M100.93%10.06M100.93%10.06M
Current deferred assets --26.93K--16.75K--0--202.86K--202.86K--------------0--0
Other current assets -66.32%388.04K-64.44%637.09K-57.78%786.05K-66.54%839.59K-66.54%839.59K-31.12%1.15M-26.52%1.79M-18.80%1.86M1.47%2.51M1.47%2.51M
Total current assets 258.32%7.39M-64.66%2.15M-77.03%1.6M-87.34%1.59M-87.34%1.59M-76.30%2.06M-46.73%6.07M-52.68%6.97M68.03%12.56M68.03%12.56M
Non current assets
Net PPE -19.25%2.8K5.06%3.55K-1.82%4.31K-12.91%4.93K-12.91%4.93K-59.28%3.47K-69.17%3.38K-65.56%4.39K-64.84%5.66K-64.84%5.66K
Non current prepaid assets -93.01%18.37K-15.08%320.32K-87.38%55.3K-78.30%104.75K-78.30%104.75K-55.84%262.73K-46.48%377.2K-44.67%438.13K-48.07%482.81K-48.07%482.81K
Total non current assets -92.05%21.18K-14.90%323.87K-86.53%59.6K-77.55%109.68K-77.55%109.68K-71.61%266.2K-63.75%380.58K-61.14%442.52K-61.84%488.47K-61.84%488.47K
Total assets 218.26%7.41M-61.73%2.47M-77.60%1.66M-86.97%1.7M-86.97%1.7M-75.84%2.33M-48.17%6.45M-53.28%7.41M49.05%13.05M49.05%13.05M
Liabilities
Current liabilities
Payables --------------------300.67%4.03M627.39%3.57M467.80%2.78M--------
-accounts payable --------------------300.67%4.03M627.39%3.57M467.80%2.78M--------
Current accrued expenses -------------------------5.94%260.14K177.91%853.23K--------
Current debt and capital lease obligation -25.58%31.19K-25.93%123.25K-26.28%213.1K-26.63%300.81K-26.63%300.81K6.73%41.9K6.39%166.4K6.05%289.08K5.72%409.97K5.72%409.97K
-Current debt -25.58%31.19K-25.93%123.25K-26.28%213.1K-26.63%300.81K-26.63%300.81K6.73%41.9K6.39%166.4K6.05%289.08K5.72%409.97K5.72%409.97K
Current liabilities -0.29%4.06M69.19%6.76M55.28%6.09M24.65%6.13M24.65%6.13M226.99%4.07M332.66%4M266.87%3.92M89.66%4.92M89.66%4.92M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -0.29%4.06M69.19%6.76M55.28%6.09M24.65%6.13M24.65%6.13M226.99%4.07M332.66%4M266.87%3.92M89.66%4.92M89.66%4.92M
Shareholders'equity
Share capital 695.01%33.45K-65.15%1.44K379.29%10.67K284.29%6.21K284.29%6.21K-89.49%4.21K-89.66%4.14K-94.44%2.23K70.39%1.62K70.39%1.62K
-common stock 695.01%33.45K-65.15%1.44K379.29%10.67K284.29%6.21K284.29%6.21K-89.49%4.21K-89.66%4.14K-94.44%2.23K70.39%1.62K70.39%1.62K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -26.57%-81.25M-26.77%-75.64M-31.38%-73.11M-37.17%-69.57M-37.17%-69.57M-43.44%-64.19M-44.36%-59.67M-47.34%-55.65M-43.10%-50.72M-43.10%-50.72M
Paid-in capital 35.42%84.57M14.86%71.35M16.12%68.67M10.67%65.13M10.67%65.13M17.59%62.45M17.61%62.12M12.58%59.14M41.45%58.85M41.45%58.85M
Total stockholders'equity 292.58%3.35M-274.93%-4.29M-226.88%-4.43M-154.50%-4.43M-154.50%-4.43M-120.74%-1.74M-78.70%2.45M-76.41%3.49M31.96%8.13M31.96%8.13M
Total equity 292.58%3.35M-274.93%-4.29M-226.88%-4.43M-154.50%-4.43M-154.50%-4.43M-120.74%-1.74M-78.70%2.45M-76.41%3.49M31.96%8.13M31.96%8.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data